Dry formulations of vaccines that are room temperature stable
US9839613B2 · kind B2 · utility
5Cited by
24References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 26, 2014 |
| Grant date | Dec 12, 2017 |
| Priority date | — |
| Expiry date | Sep 26, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18471
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses dry formulations of room temperature stable vaccines that comprise a live attenuated virus, a sugar stabilizer, and an amino acid stabilizer. The present invention also discloses the manufacture of such vaccines and methods of protecting an animal by administration of such vaccines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.